跳至主要内容
临床试验/TCTR20201003003
TCTR20201003003已完成1 期

Efficacy and Safety of Prasaprohyai Remedy, a Thai traditional remedy compared to Loratadine in Allergic Rhinitis Patients.

Faculty of Medicine, Thammasat univercity0 个研究点目标入组 63 人开始时间: 2020年10月3日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 80 Years(—)
性别
All

入选标准

  • age in range 20 - 80 years old, diagnosed with moderate disease symptoms of allergic rhinitis (classified followed ARIA criteria), ceased using antihistamine at least 7 days before participating.

排除标准

  • The patients who used nasal spray, had nasal polyp, were pregnant or lactating, had nasal septal perforations or had sinus surgery, patients with serious medical conditions such as congestive heart disease, liver and renal dysfunction, uncontrolled hypertension, severe asthma, tuberculosis, HIV were excluded.

研究者

发起方
Faculty of Medicine, Thammasat univercity

相似试验